indanidine has been researched along with albuterol in 1 studies
| Studies (indanidine) | Trials (indanidine) | Recent Studies (post-2010) (indanidine) | Studies (albuterol) | Trials (albuterol) | Recent Studies (post-2010) (albuterol) |
|---|---|---|---|---|---|
| 26 | 0 | 1 | 10,108 | 3,059 | 2,058 |
| Protein | Taxonomy | indanidine (IC50) | albuterol (IC50) |
|---|---|---|---|
| Beta-2 adrenergic receptor | Homo sapiens (human) | 1.2618 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| De Jonge, A; Mathy, MJ; Thoolen, MJ; Timmermans, PB; Van Zwieten, PA; Wilffert, B | 1 |
1 other study(ies) available for indanidine and albuterol
| Article | Year |
|---|---|
Sgd 101/75 is distinguished from other selective alpha 1-adrenoceptor agonists by the inhibition of its pressor responses by calcium entry blockade and vasodilatation in pithed rats and cats.
Topics: Adrenergic alpha-Agonists; Albuterol; Animals; Blood Pressure; Calcium Channel Blockers; Cats; Clonidine; Decerebrate State; Dose-Response Relationship, Drug; Male; Nifedipine; Rats; Rats, Inbred Strains; Vasoconstriction; Vasodilation | 1983 |